SIGN IN
Director, Global Therapy Guidance Growth Strategy jobs in United States
cer-icon
Apply on Employer Site
company-logo

GE HealthCare · 2 days ago

Director, Global Therapy Guidance Growth Strategy

GE HealthCare’s Oncology business is advancing precision cancer care through digital therapy guidance and imaging integration. The Director, Global Therapy Guidance Growth & Commercial Strategy will lead cross-portfolio integration and develop scalable commercial strategies to expand GE’s Oncology growth globally.
AppsHealth CareHealth DiagnosticsHome ImprovementHome RenovationInternetMedical
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Lead the global Therapy Guidance growth strategy, integrating iRT, MIM, BK, CT/MR, and Theranostics into a cohesive Oncology ecosystem
Partner with Product, Marketing, and Regional Commercial teams to create unified go-to-market plans that link Oncology workflows to measurable Imaging pull-through
Drive IRT adoption and reference-site success globally, tracking downstream Imaging and Software revenue influence
Develop and deploy commercial playbooks, value maps, and enablement tools to accelerate regional execution
Strengthen strategic alliances with Elekta, RaySearch, Caption Health, and BK Ultrasound to expand Therapy Guidance capabilities and visibility
Collaborate with the VP of Academic Partnerships to enable research collaborations, KOL engagement, and peer-to-peer programs
Launch and manage a global Oncology growth dashboard capturing Therapy Guidance adoption, Imaging impact, and partnership metrics
Represent GE HealthCare at key Oncology and Imaging conferences (ASTRO, ESTRO, RSNA, AAPM) to position GE as the industry leader in integrated Oncology workflows
Identify new access opportunities such as AI-guided handheld ultrasound for brachytherapy and prostate workflows that can drive Imaging utilization
Provide regular business reviews and pipeline forecasts demonstrating Imaging and Software growth influenced by Therapy Guidance initiatives

Qualification

Oncology experienceCommercial strategy developmentRadiation therapy planningPartnership buildingGlobal commercialization frameworksRadiation oncology specializationCross-functional initiativesResearch design initiativesCommunication skillsPresentation skills

Required

Bachelor's degree in business, healthcare, or related field; advanced degree (MBA, MS, or MPH) preferred
10+ years of Oncology experience working in radiation oncology clinics and in industry
Proven success developing and executing commercial strategies that connect clinical workflows to revenue outcomes
Experience managing cross-functional initiatives and influencing senior stakeholders in matrix organizations
Strong understanding of radiation therapy planning, oncology imaging, and workflow integration
Experience contributing to research design initiatives
Excellent communication and presentation skills, with ability to engage clinical and executive audiences
Willingness to travel globally

Preferred

15+ years of Oncology experience working in radiation oncology clinics and in industry
Strong record of leading cross-portfolio collaboration and commercial execution across Oncology and Imaging
Demonstrated ability to translate clinical insight into scalable business strategy
Experience building partnerships with major Oncology ecosystem players and academic collaborators
Strategic mindset with ability to design and implement global commercialization frameworks
Collaborative and entrepreneurial, with proven ability to unite diverse teams around shared objectives
Preferred radiation oncology clinical specialization skills in one of the following areas: Dosimetry, Physics, Therapist

Benefits

Medical
Dental
Vision
Paid time off
A 401(k) plan with employee and company contribution opportunities
Life
Disability
Accident insurance
Tuition reimbursement

Company

GE HealthCare

company-logo
GE Healthcare provides a wide range of medical technologies and services to healthcare providers and researchers. It is a sub-organization of General Electric.

Funding

Current Stage
Public Company
Total Funding
$5.52B
Key Investors
Bill & Melinda Gates Foundation
2024-11-07Post Ipo Secondary· $1.17B
2024-09-12Post Ipo Secondary· $1.29B
2024-02-16Post Ipo Secondary· $1.07B

Leadership Team

leader-logo
Catherine Estrampes
President and CEO, US & Canada
linkedin
leader-logo
Luiz Verzegnassi
President & CEO, Services
linkedin
Company data provided by crunchbase